For a 15-year-old male with an ingrown left great toe nail and cellulitis who underwent a partial nail matrix excision under lidocaine, what are the appropriate CPT code and ICD-10-CM diagnosis codes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CPT and ICD-10-CM Coding for Partial Nail Matrix Excision with Cellulitis

For this 15-year-old with an ingrown toenail and cellulitis who underwent partial nail matrix excision under lidocaine anesthesia, use CPT code 11750 (excision of nail and nail matrix, partial or complete) and ICD-10-CM codes L60.0 (ingrowing nail) as primary diagnosis and L03.046 (cellulitis of left toe) as secondary diagnosis.

CPT Code Selection

The appropriate CPT code is 11750 - this specifically covers excision of nail and nail matrix, partial or complete (including nail bed), for permanent removal. This is the standard code for partial nail matrix excision procedures (Winograd procedure or similar techniques).

  • The lidocaine anesthesia is included in the procedure code and should not be billed separately 1
  • Do not use a separate code for the local anesthetic administration - it's bundled into the surgical procedure
  • If phenol or sodium hydroxide was used for chemical matrixectomy, this is still coded as 11750

ICD-10-CM Diagnosis Codes

Primary diagnosis: L60.0 (Ingrowing nail)

  • This is the definitive code for ingrown toenails (unguis incarnatus) 2
  • Use this as the primary diagnosis since it's the reason for the surgical procedure

Secondary diagnosis: L03.046 (Cellulitis of left toe)

  • This captures the infectious complication requiring continued antibiotic therapy 3, 4
  • The specificity includes laterality (left) and anatomic location (toe), which is important for accurate coding
  • Document this as it justifies the clinical severity and may support medical necessity

Clinical Documentation Considerations

Ensure your documentation includes:

  • Specific toe involved (left great toe - already documented)
  • Stage of ingrown nail (appears to be stage II-III given cellulitis and failed antibiotic therapy) 2
  • Previous treatment attempted (antibiotics from last week's visit)
  • Extent of matrix excision performed (partial)
  • Type of anesthesia used (lidocaine - already documented)

Important Coding Pitfalls to Avoid

Do not code:

  • Separate E/M visit on same day unless significant separately identifiable service was provided with modifier -25
  • Separate anesthesia code - local anesthesia is bundled 1
  • Incision and drainage code (10060/10061) - the matrix excision is the definitive procedure

Common error: Using L03.90 (cellulitis, unspecified) instead of the specific L03.046 code loses important anatomic detail and laterality that improves coding accuracy and reimbursement.

Antibiotic Continuation Note

Given the persistent cellulitis despite prior antibiotics, ensure continued antibiotic coverage active against streptococci and consider MRSA coverage given the purulent nature and treatment failure 3. The surgical intervention (matrix excision) addresses the underlying cause while antibiotics treat the superimposed infection - both are medically necessary and should be documented as such.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.